Explained herein are pharmaceutical packaging units which protect against oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-delicate medicines, these devices such as a syringe using an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with quite reduced permeability to oxygen an